NEW YORK (
) hit a new 52-week high Wednesday as it is currently trading at $95.13, above its previous 52-week high of $94.90 with 29,228 shares traded as of 9:39 a.m. ET. Average volume has been one million shares over the past 30 days.
DaVita has a market cap of $8.86 billion and is part of the
industry. Shares are up 24.1% year to date as of the close of trading on Tuesday.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. The company has a P/E ratio of 17.2, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
TheStreet Ratings rates DaVita as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, impressive record of earnings per share growth, compelling growth in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full
52-week high stocks
or get investment ideas from our